Table 2.
Chemical class | HDAC inhibitor | Reported targets |
---|---|---|
Benzamides | SNDX-275 (MS-275, Entinostat) | HDAC-1,-2,-3 |
CI-994 (Tacedinaline) | HDAC-1, -2 | |
MGCD-0103 | HDAC-1, -2, -3, 11 | |
Short Chain Fatty Acids | Valproic acid (VPA) | Class I and IIa |
Sodium butyrate | Class I and IIa, IV | |
Phenyl butyrate (S-HDAC-42, AR-42) | Class I, II | |
Cyclic Peptides | Depsipeptide (Romidepsin) | HDAC -1, -2 |
Apicidin | Class I | |
Hydroxamic Acids | JNJ-26481585 | Class I and II, IV |
Suberoylanilide hydroxamic acid (SAHA; Vorinostat) | Class I and II, IV | |
Trichostatin-A (TSA) | Class I and II, IV | |
LBH589 (Panobinostat) | Class I and II, IV | |
ITF2357 (Gavinostat) | Class I and II | |
PXD101 (Belinostat) | Class I and II, IV | |
NVP-LAQ824 (Dacinostat) | Class I | |
Suberoylanilide bis-hydroxamic acid (SBHA) | HDAC-1, -3 | |
RAS2410 (Resminostat) | HDAC-1, -3, -6 | |
ACY-1215 (Rocilinostat) | HDAC-6 | |
CR-2408 | Class I, II, IV | |
Mercaptoketone | KD5170 | Class I and II |
Others | Tubacin | HDAC-6 |